The Safety and Efficacy of 5% Lidocaine Patch and Flurbiprofen Patch for Relieving Acute Low Back Pain
Status:
Recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, single blinded, two-arm, head to head study.
The purpose of this study is:
- To evaluate and compare the efficacy of 5% lidocaine patch and flurbiprofen patch for
treatment of acute low back pain.
Determining the effect of the 5% lidocaine patch and flurbiprofen patch for improving
functional disabilities and in reducing pain resulting from acute low back pain. Efficacy
will be determined by the level of pain relief (as measured by the Numerical Rating Scale,
NRS), decrease in analgesics, improved quality of life (as measured by the Oswestry
Disability Questionnaire, ODQ, and core outcome measures index questionnaire, COMI), pain
interference with function (as measured by the Brief Pain Inventory-Interference scale,
BPI-QoL), Short-Form McGill Pain Questionnaire-2(SF-MPQ-2), general health status (as
measured by the EQ5D), Overall treatment effect (OTE), physical exam from baseline up to
1-Months.